Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
106.56
Dollar change
-4.03
Percentage change
-3.64
%
IndexNDX, S&P 500 P/E- EPS (ttm)-12.41 Insider Own12.19% Shs Outstand382.00M Perf Week2.37%
Market Cap40.80B Forward P/E- EPS next Y-5.21 Insider Trans-0.49% Shs Float336.22M Perf Month9.31%
Income-4714.00M PEG- EPS next Q-3.45 Inst Own65.84% Short Float6.61% Perf Quarter5.79%
Sales6.86B P/S5.95 EPS this Y41.66% Inst Trans0.90% Short Ratio5.01 Perf Half Y7.16%
Book/sh36.27 P/B2.94 EPS next Y27.60% ROA-21.18% Short Interest22.23M Perf Year-27.47%
Cash/sh22.52 P/C4.73 EPS next 5Y- ROE-28.59% 52W Range62.55 - 163.24 Perf YTD7.15%
Dividend Est.- P/FCF- EPS past 5Y-20.02% ROI-31.28% 52W High-34.72% Beta1.62
Dividend TTM- Quick Ratio3.36 Sales past 5Y827.00% Gross Margin22.52% 52W Low70.36% ATR (14)4.84
Dividend Ex-Date- Current Ratio3.42 EPS Y/Y TTM-158.58% Oper. Margin-61.71% RSI (14)55.19 Volatility4.60% 4.56%
Employees5600 Debt/Eq0.09 Sales Y/Y TTM-64.12% Profit Margin-68.76% Recom2.27 Target Price129.46
Option/ShortYes / Yes LT Debt/Eq0.09 EPS Q/Q-84.81% Payout0.00% Rel Volume0.89 Prev Close110.59
Sales Surprise11.94% EPS Surprise155.74% Sales Q/Q-44.05% EarningsFeb 22 BMO Avg Volume4.44M Price106.56
SMA203.15% SMA507.61% SMA2006.05% Trades Volume3,955,885 Change-3.64%
Date Action Analyst Rating Change Price Target Change
Feb-26-24Downgrade HSBC Securities Hold → Reduce $75 → $86
Jan-02-24Upgrade Oppenheimer Perform → Outperform $142
Nov-29-23Initiated Canaccord Genuity Hold $82
Nov-03-23Upgrade HSBC Securities Reduce → Hold $89 → $69
Nov-02-23Downgrade Deutsche Bank Hold → Sell $125 → $60
Aug-04-23Downgrade TD Cowen Outperform → Market Perform $145 → $125
Aug-03-23Downgrade Deutsche Bank Buy → Hold $125
Jul-24-23Initiated William Blair Mkt Perform $136.28
Jul-14-23Initiated HSBC Securities Reduce $97
Jun-26-23Upgrade UBS Neutral → Buy $221 → $191
Today 04:49PM
11:38AM
05:55AM
Mar-27-24 03:22PM
02:36PM
02:13PM Loading…
02:13PM
01:21PM
12:24PM
11:01AM
10:46AM
09:53AM
09:33AM
08:50AM
08:50AM
08:19AM
08:15AM Loading…
08:15AM
07:55AM
06:59AM
06:51AM
06:34AM
06:30AM
06:30AM
Mar-26-24 02:15PM
01:51PM
10:33AM
09:50AM
08:13AM
07:00AM
Mar-23-24 05:50AM
03:46AM
08:03PM Loading…
Mar-21-24 08:03PM
11:38AM
09:17AM
04:39AM
Mar-20-24 02:11PM
Mar-19-24 08:30AM
Mar-18-24 05:50PM
08:11AM
06:50AM
Mar-17-24 05:20PM
Mar-15-24 12:39PM
10:36AM
Mar-13-24 09:24AM
07:07AM
06:12AM
Mar-12-24 05:50PM
12:06PM
08:30AM
08:03AM
08:00AM
Mar-11-24 05:10PM
04:53PM
04:24PM
03:29PM
08:53AM
Mar-09-24 01:09PM
Mar-08-24 05:04PM
10:10AM
Mar-07-24 12:07PM
Mar-06-24 06:30AM
Mar-05-24 01:05PM
09:20AM
Mar-04-24 08:28PM
11:02AM
Mar-03-24 01:17PM
05:45AM
Mar-02-24 01:10PM
10:42AM
09:30AM
08:45AM
Mar-01-24 07:00AM
Feb-29-24 04:49PM
07:00AM
05:50AM
Feb-28-24 07:00AM
06:38AM
Feb-27-24 11:43AM
Feb-26-24 02:43PM
11:17AM
09:34AM
08:58AM
07:42AM
05:51AM
Feb-23-24 12:31PM
12:21PM
04:22AM
02:49AM
Feb-22-24 10:40PM
04:10PM
02:36PM
02:21PM
01:39PM
01:29PM
01:08PM
12:43PM
12:30PM
12:21PM
11:42AM
11:24AM
11:22AM
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AFEYAN NOUBARDirectorMar 20 '24Sale102.3915,0001,535,8202,116,931Mar 22 07:00 PM
Hoge StephenPresidentMar 15 '24Sale103.1715,0001,547,5501,501,241Mar 19 04:39 PM
AFEYAN NOUBARDirectorMar 13 '24Sale108.5415,0001,628,0312,131,931Mar 15 07:00 PM
Klinger Shannon ThymeChief Legal OfficerMar 08 '24Sale99.0554453,8849,267Mar 11 09:05 AM
Hoge StephenPresidentMar 04 '24Sale94.3430929,1511,516,241Mar 05 05:52 PM
Klinger Shannon ThymeChief Legal OfficerMar 04 '24Sale94.3411711,0388,673Mar 05 05:56 PM
Hoge StephenPresidentFeb 29 '24Sale94.572,388225,8381,515,898Mar 01 05:25 PM
Klinger Shannon ThymeChief Legal OfficerFeb 29 '24Sale94.5767063,3638,557Mar 01 05:29 PM
Mock James MChief Financial OfficerFeb 29 '24Sale94.5764761,1884,300Mar 01 05:33 PM
Hoge StephenPresidentFeb 22 '24Sale100.0015,0001,500,0001,513,433Feb 23 04:04 PM
Bancel StephaneChief Executive OfficerFeb 16 '24Sale88.8826,3512,342,0985,460,224Feb 16 04:10 PM
Hoge StephenPresidentFeb 16 '24Sale88.8810,542936,9811,528,433Feb 16 04:19 PM
Hoge StephenPresidentFeb 12 '24Sale86.2330426,2141,516,281Feb 13 04:13 PM
Hoge StephenPresidentJan 16 '24Sale103.9015,0001,558,5001,516,063Jan 17 04:12 PM
Mock James MChief Financial OfficerJan 08 '24Sale109.7577284,7313,632Jan 09 04:08 PM
Hoge StephenPresidentDec 27 '23Sale100.0145,0004,500,4501,531,063Dec 28 08:00 AM
Klinger Shannon ThymeChief Legal OfficerDec 08 '23Sale79.0956344,5257,912Dec 11 04:03 PM
Garay ArpaChief Commercial OfficerDec 06 '23Sale78.3456444,1823,690Dec 07 04:21 PM
Hoge StephenPresidentDec 04 '23Sale79.3130924,5081,576,063Dec 05 04:07 PM
Klinger Shannon ThymeChief Legal OfficerDec 04 '23Sale79.311118,8047,336Dec 05 04:10 PM
Hoge StephenPresidentNov 29 '23Sale79.811,13690,6661,575,721Nov 30 04:11 PM
Hoge StephenPresidentNov 10 '23Sale68.7626318,0841,574,446Nov 13 04:02 PM
AFEYAN NOUBARDirectorNov 01 '23Sale76.0010,000760,0322,146,931Nov 03 07:00 PM
AFEYAN NOUBARDirectorOct 25 '23Sale76.9910,000769,8542,156,931Oct 27 07:00 PM
AFEYAN NOUBARDirectorOct 11 '23Sale103.3015,0001,549,4412,166,931Oct 13 07:00 PM
Mock James MChief Financial OfficerOct 06 '23Sale102.502,858292,9532,952Oct 10 04:51 PM
AFEYAN NOUBARDirectorOct 04 '23Sale102.7215,0001,540,8452,181,931Oct 06 07:02 PM
AFEYAN NOUBARDirectorSep 27 '23Sale98.9610,000989,6462,196,931Sep 29 07:00 PM
AFEYAN NOUBARDirectorSep 20 '23Sale104.7415,0001,571,0902,206,931Sep 22 07:00 PM
Hoge StephenPresidentSep 15 '23Sale112.9915,0001,694,8501,574,187Sep 18 04:06 PM
AFEYAN NOUBARDirectorSep 13 '23Sale109.7015,0001,645,5222,221,931Sep 15 07:00 PM
Klinger Shannon ThymeChief Legal OfficerSep 08 '23Sale107.2255759,7227,215Sep 11 04:02 PM
AFEYAN NOUBARDirectorSep 06 '23Sale107.6115,0001,614,0941,982,209Sep 08 07:01 PM
Garay ArpaChief Commercial OfficerSep 06 '23Sale108.4057462,2193,113Sep 07 04:46 PM
Hoge StephenPresidentSep 05 '23Sale111.4432035,6601,589,187Sep 06 04:08 PM
Klinger Shannon ThymeChief Legal OfficerSep 05 '23Sale111.4411512,8156,634Sep 06 04:17 PM
AFEYAN NOUBARDirectorAug 30 '23Sale115.4615,0001,731,9511,997,209Sep 01 07:00 PM
Hoge StephenPresidentAug 29 '23Sale115.011,135130,5421,588,855Aug 30 04:07 PM
AFEYAN NOUBARDirectorAug 23 '23Sale115.5115,0001,732,6132,012,209Aug 25 07:00 PM
Hoge StephenPresidentAug 17 '23Sale100.0015,0001,500,0001,587,579Aug 18 05:16 PM
AFEYAN NOUBARDirectorAug 16 '23Sale97.5610,000975,6142,027,209Aug 18 07:01 PM
Hoge StephenPresidentAug 10 '23Sale102.5324725,3251,602,579Aug 11 04:18 PM
AFEYAN NOUBARDirectorAug 02 '23Sale110.9915,0001,664,8762,037,209Aug 04 07:00 PM
AFEYAN NOUBARDirectorJul 26 '23Sale120.4215,0001,806,2292,052,209Jul 28 07:05 PM
AFEYAN NOUBARDirectorJul 19 '23Sale125.4815,0001,882,1522,067,209Jul 21 07:00 PM
Hoge StephenPresidentJul 17 '23Sale120.6015,0001,809,0001,602,303Jul 18 04:35 PM
AFEYAN NOUBARDirectorJul 12 '23Sale125.8115,0001,887,0812,082,209Jul 14 07:01 PM
AFEYAN NOUBARDirectorJul 05 '23Sale124.7315,0001,870,9332,097,209Jul 07 07:00 PM
Bancel StephaneChief Executive OfficerJun 28 '23Option Exercise0.9927,15526,8835,439,101Jun 30 04:51 PM
Bancel StephaneChief Executive OfficerJun 28 '23Sale121.6327,1553,302,9075,411,946Jun 30 04:51 PM
AFEYAN NOUBARDirectorJun 28 '23Sale121.5415,0001,823,1602,112,209Jun 30 07:02 PM
Bancel StephaneChief Executive OfficerJun 22 '23Option Exercise0.9940,00039,6005,451,946Jun 23 04:03 PM
Bancel StephaneChief Executive OfficerJun 22 '23Sale119.4140,0004,776,4275,411,946Jun 23 04:03 PM
Bancel StephaneChief Executive OfficerJun 21 '23Option Exercise0.9940,00039,6005,451,946Jun 23 04:03 PM
Bancel StephaneChief Executive OfficerJun 21 '23Sale121.9840,0004,879,2875,411,946Jun 23 04:03 PM
AFEYAN NOUBARDirectorJun 21 '23Sale121.9515,0001,829,2272,127,209Jun 23 07:01 PM
Bancel StephaneChief Executive OfficerJun 15 '23Option Exercise0.9940,00039,6005,451,946Jun 16 04:15 PM
Bancel StephaneChief Executive OfficerJun 15 '23Sale128.4140,0005,136,3885,411,946Jun 16 04:15 PM
Hoge StephenPresidentJun 15 '23Sale125.9315,0001,888,9501,617,303Jun 16 04:10 PM
Bancel StephaneChief Executive OfficerJun 14 '23Option Exercise0.9940,00039,6005,451,946Jun 16 04:15 PM
Bancel StephaneChief Executive OfficerJun 14 '23Sale126.1440,0005,045,4865,411,946Jun 16 04:15 PM
AFEYAN NOUBARDirectorJun 14 '23Sale126.1815,0001,892,6272,142,209Jun 16 07:00 PM
Bancel StephaneChief Executive OfficerJun 08 '23Option Exercise0.9940,00039,6005,451,946Jun 09 04:14 PM
Bancel StephaneChief Executive OfficerJun 08 '23Sale124.0140,0004,960,3645,411,946Jun 09 04:14 PM
Klinger Shannon ThymeChief Legal OfficerJun 08 '23Sale124.0956570,1116,516Jun 09 04:09 PM
Bancel StephaneChief Executive OfficerJun 07 '23Option Exercise0.9940,00039,6005,451,946Jun 09 04:14 PM
Bancel StephaneChief Executive OfficerJun 07 '23Sale125.8140,0005,032,4205,411,946Jun 09 04:14 PM
AFEYAN NOUBARDirectorJun 07 '23Sale125.9115,0001,888,6012,157,209Jun 09 07:00 PM
Garay ArpaChief Commercial OfficerJun 06 '23Sale125.752,290287,9722,547Jun 07 04:05 PM
Hoge StephenPresidentJun 02 '23Sale130.3230940,2701,632,303Jun 05 04:16 PM
Klinger Shannon ThymeChief Legal OfficerJun 02 '23Sale130.3211014,3365,942Jun 05 04:20 PM
Bancel StephaneChief Executive OfficerJun 01 '23Option Exercise0.9940,00039,6005,451,946Jun 02 04:46 PM
Bancel StephaneChief Executive OfficerJun 01 '23Sale127.9640,0005,118,4735,411,946Jun 02 04:46 PM
Bancel StephaneChief Executive OfficerMay 31 '23Option Exercise0.9940,00039,6005,451,946Jun 02 04:46 PM
Bancel StephaneChief Executive OfficerMay 31 '23Sale126.9140,0005,076,5585,411,946Jun 02 04:46 PM
AFEYAN NOUBARDirectorMay 31 '23Sale127.3515,0001,910,3222,172,209Jun 02 07:00 PM
Hoge StephenPresidentMay 30 '23Sale124.951,181147,5691,631,961May 31 04:21 PM
Bancel StephaneChief Executive OfficerMay 25 '23Option Exercise0.9940,00039,6005,451,946May 26 04:59 PM
Bancel StephaneChief Executive OfficerMay 25 '23Sale127.3640,0005,094,4215,411,946May 26 04:59 PM
Bancel StephaneChief Executive OfficerMay 24 '23Option Exercise0.9940,00039,6005,451,946May 26 04:59 PM
Bancel StephaneChief Executive OfficerMay 24 '23Sale131.4340,0005,257,2125,411,946May 26 04:59 PM
Bancel StephaneChief Executive OfficerMay 18 '23Option Exercise0.9940,00039,6005,451,946May 19 04:12 PM
Bancel StephaneChief Executive OfficerMay 18 '23Sale123.7740,0004,950,9995,411,946May 19 04:12 PM
Bancel StephaneChief Executive OfficerMay 17 '23Option Exercise0.9940,00039,6005,451,946May 19 04:12 PM
Bancel StephaneChief Executive OfficerMay 17 '23Sale125.3240,0005,012,6485,411,946May 19 04:12 PM
Bancel StephaneChief Executive OfficerMay 11 '23Option Exercise0.9940,00039,6005,451,946May 12 04:08 PM
Bancel StephaneChief Executive OfficerMay 11 '23Sale127.2640,0005,090,4865,411,946May 12 04:08 PM
Bancel StephaneChief Executive OfficerMay 10 '23Option Exercise0.9940,00039,6005,451,946May 12 04:08 PM
Bancel StephaneChief Executive OfficerMay 10 '23Sale131.6040,0005,264,0325,411,946May 12 04:08 PM
Hoge StephenPresidentMay 10 '23Sale133.3725033,3441,630,732May 11 04:09 PM
Bancel StephaneChief Executive OfficerMay 04 '23Option Exercise0.9940,00039,6005,451,946May 05 04:08 PM
Bancel StephaneChief Executive OfficerMay 04 '23Sale135.7040,0005,428,1255,411,946May 05 04:08 PM
Bancel StephaneChief Executive OfficerMay 03 '23Option Exercise0.9940,00039,6005,451,946May 05 04:08 PM
Bancel StephaneChief Executive OfficerMay 03 '23Sale131.2940,0005,251,4985,411,946May 05 04:08 PM
Bancel StephaneChief Executive OfficerApr 27 '23Option Exercise0.9940,00039,6005,451,946Apr 28 04:51 PM
Bancel StephaneChief Executive OfficerApr 27 '23Sale130.6140,0005,224,5705,411,946Apr 28 04:51 PM
Bancel StephaneChief Executive OfficerApr 26 '23Option Exercise0.9940,00039,6005,451,946Apr 28 04:51 PM
Bancel StephaneChief Executive OfficerApr 26 '23Sale131.7340,0005,269,1405,411,946Apr 28 04:51 PM
Bancel StephaneChief Executive OfficerApr 20 '23Option Exercise0.9940,00039,6005,451,946Apr 21 05:05 PM
Bancel StephaneChief Executive OfficerApr 20 '23Sale142.9940,0005,719,5405,411,946Apr 21 05:05 PM
Last Close
Mar 28 04:00PM ET
73.94
Dollar change
-0.18
Percentage change
-0.24
%
TMDX Transmedics Group Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-0.77 Insider Own3.79% Shs Outstand32.67M Perf Week-0.05%
Market Cap2.42B Forward P/E128.80 EPS next Y0.57 Insider Trans-9.68% Shs Float31.48M Perf Month-9.83%
Income-25.03M PEG- EPS next Q-0.02 Inst Own109.01% Short Float17.18% Perf Quarter-8.19%
Sales241.62M P/S10.01 EPS this Y95.31% Inst Trans21.34% Short Ratio8.73 Perf Half Y29.92%
Book/sh4.20 P/B17.61 EPS next Y1689.57% ROA-5.09% Short Interest5.41M Perf Year-1.00%
Cash/sh12.07 P/C6.13 EPS next 5Y- ROE-15.42% 52W Range36.42 - 99.63 Perf YTD-6.32%
Dividend Est.- P/FCF- EPS past 5Y8.36% ROI-3.84% 52W High-25.79% Beta1.98
Dividend TTM- Quick Ratio8.49 Sales past 5Y95.07% Gross Margin63.77% 52W Low103.02% ATR (14)4.20
Dividend Ex-Date- Current Ratio9.30 EPS Y/Y TTM38.28% Oper. Margin-0.63% RSI (14)41.18 Volatility5.00% 5.25%
Employees584 Debt/Eq3.76 Sales Y/Y TTM158.53% Profit Margin-10.36% Recom1.29 Target Price99.33
Option/ShortYes / Yes LT Debt/Eq3.75 EPS Q/Q156.17% Payout- Rel Volume1.41 Prev Close74.12
Sales Surprise18.51% EPS Surprise273.41% Sales Q/Q158.72% EarningsFeb 26 AMC Avg Volume619.51K Price73.94
SMA20-6.35% SMA50-11.15% SMA2002.45% Trades Volume876,307 Change-0.24%
Date Action Analyst Rating Change Price Target Change
TodayInitiated Piper Sandler Overweight $95
Jul-19-23Initiated Robert W. Baird Outperform
Aug-02-22Upgrade JP Morgan Neutral → Overweight $48
Oct-08-20Downgrade JP Morgan Overweight → Neutral $15
Apr-07-20Initiated Oppenheimer Outperform $25
May-28-19Initiated Morgan Stanley Equal-Weight
May-28-19Initiated JP Morgan Overweight
May-28-19Initiated Cowen Outperform
May-28-19Initiated Canaccord Genuity Buy
Mar-19-24 04:05PM
Mar-05-24 11:52PM
08:02AM
Mar-03-24 06:23AM
Mar-01-24 08:45AM
04:06PM Loading…
Feb-28-24 04:06PM
04:05PM
11:00AM
Feb-27-24 05:59PM
08:10AM
Feb-26-24 05:38PM
04:53PM
04:05PM
Feb-18-24 06:37AM
Feb-16-24 04:05PM
04:04PM Loading…
Feb-15-24 04:04PM
Feb-12-24 04:05PM
05:37AM
Feb-10-24 02:07AM
Feb-02-24 11:02PM
Jan-29-24 03:50PM
Jan-25-24 03:15PM
Jan-22-24 10:30AM
Jan-16-24 04:05PM
Dec-29-23 08:52AM
Dec-27-23 05:50AM
Dec-26-23 01:36PM
Dec-18-23 04:05PM
Dec-12-23 04:05PM
Nov-30-23 05:50AM
05:50AM Loading…
Nov-25-23 05:50AM
Nov-23-23 05:50AM
Nov-14-23 04:05PM
Nov-12-23 05:50AM
Nov-10-23 09:30AM
05:55AM
Nov-09-23 10:23AM
05:57AM
Nov-07-23 10:16AM
10:15AM
Nov-06-23 05:19PM
04:42PM
04:05PM
01:42PM
Nov-03-23 04:05PM
Nov-01-23 05:45AM
Oct-28-23 05:50AM
Oct-23-23 04:05PM
Oct-20-23 10:15AM
Oct-14-23 05:37AM
Oct-10-23 04:05PM
Oct-05-23 05:01AM
Oct-03-23 08:50AM
Sep-28-23 11:38AM
09:37AM
Sep-13-23 04:23PM
Sep-01-23 06:00PM
Aug-29-23 05:20AM
Aug-28-23 04:05PM
Aug-17-23 11:21AM
Aug-16-23 04:05PM
Aug-12-23 08:07AM
Aug-07-23 04:05PM
Aug-06-23 06:24AM
Aug-05-23 08:32AM
Aug-04-23 03:17PM
Aug-03-23 07:25PM
06:20PM
04:05PM
Aug-02-23 05:28PM
05:00PM
Aug-01-23 11:00AM
Jul-27-23 05:25PM
Jul-26-23 05:09PM
04:05PM
Jul-20-23 04:05PM
Jun-30-23 01:21PM
Jun-29-23 11:16AM
Jun-23-23 02:05PM
Jun-15-23 03:20PM
Jun-10-23 08:00AM
Jun-09-23 02:58PM
Jun-07-23 01:53PM
May-30-23 04:05PM
May-26-23 03:59PM
May-08-23 11:21PM
07:23AM
May-06-23 08:17AM
May-05-23 05:23AM
May-04-23 10:16AM
May-02-23 12:18PM
May-01-23 05:45PM
04:05PM
08:00AM
Apr-27-23 06:22AM
Apr-26-23 10:01AM
Apr-24-23 10:00AM
04:50AM
Apr-17-23 04:05PM
Apr-06-23 12:48PM
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Khayal Tamer IChief Commercial OfficerMar 08 '24Option Exercise16.141001,61426,602Mar 12 07:31 PM
Gordon StephenChief Financial OfficerMar 08 '24Sale87.631,903166,76023,299Mar 12 07:28 PM
Khayal Tamer IChief Commercial OfficerMar 08 '24Sale87.801,417124,41325,185Mar 12 07:31 PM
Gordon StephenChief Financial OfficerMar 04 '24Option Exercise38.4615,000576,90040,202Mar 05 06:20 PM
Gordon StephenChief Financial OfficerMar 04 '24Sale82.8015,0001,242,00025,202Mar 05 06:20 PM
Khayal Tamer IChief Commercial OfficerMar 01 '24Option Exercise13.2810,000132,80036,502Mar 05 06:28 PM
TOBIN JAMES RDirectorMar 01 '24Sale83.6313,3801,118,955220,211Mar 05 06:16 PM
Khayal Tamer IChief Commercial OfficerMar 01 '24Sale82.9910,000829,89226,502Mar 05 06:28 PM
Khayal Tamer IChief Commercial OfficerFeb 20 '24Option Exercise16.142504,03514,625Feb 21 05:01 PM
Khayal Tamer IChief Commercial OfficerFeb 20 '24Sale90.0025022,50014,375Feb 21 05:01 PM
Khayal Tamer IChief Commercial OfficerFeb 16 '24Option Exercise16.082,85845,96817,233Feb 21 05:01 PM
Khayal Tamer IChief Commercial OfficerFeb 16 '24Sale90.002,858257,22014,375Feb 21 05:01 PM
Khayal Tamer IChief Commercial OfficerFeb 15 '24Option Exercise16.0077612,41615,151Feb 16 05:25 PM
Khayal Tamer IChief Commercial OfficerFeb 15 '24Sale90.0077669,84014,375Feb 16 05:25 PM
Khayal Tamer IChief Commercial OfficerFeb 14 '24Option Exercise16.003,05048,80017,425Feb 16 05:25 PM
Khayal Tamer IChief Commercial OfficerFeb 14 '24Sale90.033,050274,59214,375Feb 16 05:25 PM
Khayal Tamer IChief Commercial OfficerFeb 07 '24Option Exercise16.0073611,77615,111Feb 09 06:35 PM
Khayal Tamer IChief Commercial OfficerFeb 07 '24Sale90.0973666,30614,375Feb 09 06:35 PM
Basile Edward MDirectorFeb 06 '24Sale86.387,157618,2098,350Feb 08 04:30 PM
Gordon StephenChief Financial OfficerFeb 01 '24Option Exercise18.2115,000273,15128,075Feb 02 06:56 PM
Gordon StephenChief Financial OfficerFeb 01 '24Sale85.4515,0001,281,75013,075Feb 02 06:56 PM
Khayal Tamer IChief Commercial OfficerJan 23 '24Option Exercise16.002,33037,28016,705Jan 25 04:30 PM
Khayal Tamer IChief Commercial OfficerJan 23 '24Sale90.092,330209,91014,375Jan 25 04:30 PM
Khayal Tamer IChief Commercial OfficerJan 16 '24Option Exercise13.2810,000132,80024,375Jan 18 04:30 PM
Khayal Tamer IChief Commercial OfficerJan 16 '24Sale80.4110,000804,08814,375Jan 18 04:30 PM
Gordon StephenChief Financial OfficerJan 02 '24Option Exercise13.2815,000199,20028,075Jan 03 05:00 PM
Gordon StephenChief Financial OfficerJan 02 '24Sale77.0715,0001,156,05013,075Jan 03 05:00 PM
Provost MiriamVP, Global Regulatory AffairsDec 13 '23Option Exercise44.815,644252,91427,540Dec 15 05:31 PM
Provost MiriamVP, Global Regulatory AffairsDec 13 '23Sale75.104,122309,56223,820Dec 15 05:31 PM
TOBIN JAMES RDirectorNov 28 '23Sale70.1410,000701,400233,591Nov 29 04:38 PM
Hassanein Waleed HPresident & CEONov 07 '23Sale64.3215,000964,800514,191Nov 09 07:00 PM
Gordon StephenChief Financial OfficerOct 02 '23Option Exercise16.145,00080,70023,789Oct 04 05:00 PM
Gordon StephenChief Financial OfficerOct 02 '23Sale54.225,000271,10018,789Oct 04 05:00 PM
Hassanein Waleed HPresident & CEOSep 01 '23Sale68.267,500511,920529,191Sep 06 04:31 PM
Provost MiriamVP, Global Regulatory AffairsAug 31 '23Option Exercise26.985,480147,85726,319Sep 05 04:36 PM
Provost MiriamVP, Global Regulatory AffairsAug 31 '23Sale66.522,708180,13623,611Sep 05 04:36 PM
Weill DavidDirectorAug 29 '23Buy62.002,500155,00013,693Aug 30 04:33 PM
Hassanein Waleed HPresident & CEOAug 01 '23Sale93.067,500697,929536,691Aug 03 08:01 PM
Khayal Tamer IChief Commercial OfficerJul 18 '23Option Exercise22.665,000113,31019,375Jul 19 06:46 PM
Khayal Tamer IChief Commercial OfficerJul 18 '23Sale95.375,000476,85014,375Jul 19 06:46 PM
Khayal Tamer IChief Commercial OfficerJul 13 '23Option Exercise16.142,97448,00017,349Jul 17 04:31 PM
Khayal Tamer IChief Commercial OfficerJul 13 '23Sale90.052,974267,80914,375Jul 17 04:31 PM
Khayal Tamer IChief Commercial OfficerJul 13 '23Sale90.022,225200,29414,776Jul 17 04:31 PM
Hassanein Waleed HPresident & CEOJul 03 '23Sale82.517,500618,803544,191Jul 06 04:31 PM
Hassanein Waleed HPresident & CEOJun 01 '23Sale71.647,500537,305551,691Jun 05 04:34 PM
Gordon StephenChief Financial OfficerMay 01 '23Option Exercise16.145,00080,70023,789May 02 06:31 PM
Hassanein Waleed HPresident & CEOMay 01 '23Sale78.137,500585,989559,191May 02 06:29 PM
Gordon StephenChief Financial OfficerMay 01 '23Sale79.055,000395,25018,789May 02 06:31 PM
Khayal Tamer IChief Commercial OfficerApr 21 '23Option Exercise16.1412,026194,10026,401Apr 25 05:00 PM
Khayal Tamer IChief Commercial OfficerApr 21 '23Sale86.2812,0261,037,62614,375Apr 25 05:00 PM
Khayal Tamer IChief Commercial OfficerApr 21 '23Sale90.042,775249,86117,001Apr 25 05:00 PM
Hassanein Waleed HPresident & CEOApr 03 '23Sale74.837,500561,196566,691Apr 04 05:14 PM